Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Harvard Business School
UBS
QuintilesIMS
McKesson
Merck

Generated: November 20, 2018

DrugPatentWatch Database Preview

Sodium nitroprusside - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium nitroprusside and what is the scope of sodium nitroprusside freedom to operate?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Cipla Ltd, Medicure, Micro Labs, Mylan Labs Ltd, Namigen Llc, Nexus Pharms, Renaissance Ssa Llc, Somerset Theraps Llc, Teva Parenteral, and Exela Pharma Scs Llc, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and fifty-four drug master file entries for sodium nitroprusside. Twelve suppliers are listed for this compound.

Summary for sodium nitroprusside
Pharmacology for sodium nitroprusside
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for sodium nitroprusside

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 070566-001 Jun 9, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-001 Mar 8, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Namigen Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 207426-001 Dec 8, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 018450-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-002 Dec 7, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Renaissance Ssa Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209834-001 Jun 26, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nexus Pharms SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 207499-001 May 25, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Harvard Business School
UBS
QuintilesIMS
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.